Apr 22, 2022 02:05 PM (GMT+8) · EqualOcean
Sceneray's dual target deep brain stimulation (DBS) technology for the treatment of drug addiction indications has obtained the breakthrough medical device qualification of the U.S. Food and Drug Administration (FDA). This is the first time that Chinese enterprises have obtained breakthrough medical device qualification in the field of neurological and mental diseases.

This text is a result of machine translation.